What are you searching for?
Offering aims to improve performance, reduce risk, and help ensure smooth scale-up into manufacturing.
CCO Arul Ramadurai discusses Axplora’s strategy for high-potency growth.
Press equipped with full Band 5 containment for manufacture of highly potent drug products at clinical and commercial scales.
Twenty companies presented at the kickoff to DCAT Week.
Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO.
Subscribe to Magazine for top news, trends & analysis
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !